News last update:6 Aug 2012

Monsanto sells BST hormone business

Monsanto will sell its POSILAC bovine somatotropin (BST) business. The company said it would in future concentrate on the profitable genetically modified (GM) crops and crop protection products side of the business.

"While POSILAC is a strong product for the business, we believe repositioning the business with a strategic owner will allow Monsanto to focus on the growth of its core seeds and traits business while ensuring that loyal dairy farmers continue to receive the value of POSILAC in their operations," said Carl Casale, Monsanto's executive vice-president of strategy and operations.

BST is a controversial hormone and used to boost milk yields in the USA, but is banned in the EU on human health grounds.

Related website:

Subscribe here to the free animal feed newsletter

Editor AllAboutFeed

Or register to be able to comment.